MBX Biosciences, Inc. (MBX)
NASDAQ: MBX · Real-Time Price · USD
10.87
+0.04 (0.37%)
Sep 15, 2025, 4:00 PM EDT - Market closed

MBX Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22
365616--
Enterprise Value
141339--
Last Close Price
10.8718.43--
PB Ratio
1.672.39--
P/TBV Ratio
1.672.39--
Debt / Equity Ratio
0.000.000.000.01
Quick Ratio
19.2023.7820.6012.42
Current Ratio
19.5024.1921.2612.89
Return on Equity (ROE)
-56.28%-36.71%-53.75%-
Return on Assets (ROA)
-36.75%-24.17%-34.14%-
Return on Capital (ROIC)
-39.40%-25.23%-36.20%-
Earnings Yield
-21.09%-10.05%--
FCF Yield
-19.63%-9.02%--
Buyback Yield / Dilution
-2182.51%-944.70%-52.73%-
Updated Aug 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q